Effect of dopamine agonists and antagonists on DOPA formation in the substantia nigra

J Neurochem. 1982 Jan;38(1):75-9. doi: 10.1111/j.1471-4159.1982.tb10855.x.

Abstract

The effect of different psychotropic drugs on the rate of DOPA accumulation after administration of a decarboxylase inhibitor (NSD 1015) was compared in the substantia nigra (SN) and caudate nucleus (CN) by a new radioenzymatic method. Inhibition of monoamine oxidase with pargyline or stimulation of dopamine (DA) receptors with apomorphine, N-n-propylnorapomorphine or D-amphetamine reduced DOPA formation in the CN and SN to the same extent. Vice versa, both inhibition of DA receptors with haloperidol or (-)sulpiride and depletion of DA concentration with reserpine enhanced DOPA formation to a greater extent in the CN than in the SN. Apomorphine antagonized not only the effect of haloperidol and (-)sulpiride, but also, and even more effectively, that of reserpine. The results indicate that DA synthesis in the SN is controlled by both end-product inhibition and DA receptor-mediated mechanisms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apomorphine / pharmacology
  • Caudate Nucleus / metabolism
  • Dextroamphetamine / pharmacology
  • Dihydroxyphenylalanine / metabolism*
  • Dopamine / biosynthesis*
  • Haloperidol / pharmacology
  • Male
  • Monoamine Oxidase Inhibitors / metabolism
  • Pargyline / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Receptors, Dopamine / drug effects
  • Reserpine / pharmacology
  • Substantia Nigra / metabolism*
  • Sulpiride / pharmacology

Substances

  • Monoamine Oxidase Inhibitors
  • Receptors, Dopamine
  • Dihydroxyphenylalanine
  • Sulpiride
  • Reserpine
  • Pargyline
  • Haloperidol
  • Apomorphine
  • Dextroamphetamine
  • Dopamine